Hematology & Oncology Doctors in Boynton Beach, FL Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Rogelio A Brito, D.O. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2623 S Seacrest Blvd, Suite 216, Boynton Beach, FL 33435 Phone: 561-742-0065    Fax: 561-742-0105

Stefan Berger, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 12170 Bear River Rd, Boynton Beach, FL 33473 Phone: 561-571-1177    Fax: 561-200-0478

Dr. Victor S Koo, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2623 S Seacrest Blvd, Suite 216, Boynton Beach, FL 33435 Phone: 561-736-3888    Fax: 561-732-1737

Felix A Rodriguez-pinero, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2623 S Seacrest Blvd, Suite 216, Boynton Beach, FL 33435 Phone: 561-742-0065    Fax: 516-742-0105

Mr. Dipnarine Maharaj, MB,CHB,MD,FRCP Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10301 Hagen Ranch Rd, Suite # 600, Boynton Beach, FL 33437 Phone: 561-752-5522    Fax: 561-752-5446

Mindy S Bohrer, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2623 S Seacrest Blvd, Sute 216, Boynton Beach, FL 33435 Phone: 561-742-0065    Fax: 561-742-0105

News Archive

Excess weight contributes to higher risk of death in Asians

A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.

Morehouse School of Medicine to receive nearly $500,000 as grant from Kaiser Permanente Of Georgia

On Oct. 8, 2009, Kaiser Permanente of Georgia will present a grant for nearly $500,000 to the Satcher Health Leadership Institute at the Morehouse School of Medicine to support the development and implementation of a workforce leadership program that will reduce health disparities by creating an integrated approach to primary care and mental health.

Antibiotic resistance remains a serious health problem in Australia, warns NPS MedicineWise

In light of a major breakthrough in the quest to find new antibiotics with the discovery of teixobactin, NPS MedicineWise warns that antibiotic resistance in Australia remains a serious health problem we all need to work to address.

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.

Read more Medical News

› Verified 6 days ago